Form 4 for CRMD CorMedix Inc.
Accepted 2025-09-11 00:00:00 ET · period of report 2025-09-09 · accession 0001213900-25-087013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-11 | 2025-09-09+ | CRMD | Hurlburt Elizabeth | COO | M - OptEx | $1.45 | +54.0K | 189.9K | +40% | +$78.3K |
| DM | 2025-09-11 | 2025-09-09+ | CRMD | Hurlburt Elizabeth | COO | S - Sale+OE | $13.18 | -54.0K | 177.0K | -23% | -$711.8K |
| DM | 2025-09-11 | 2025-09-09+ | CRMD | Hurlburt Elizabeth | COO | M - OptEx | $0.00 | -54.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | M | A | 41,121 | $1.45 | 218,111 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-09 | S | D | 12,876 | $13.51 | 176,990 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $13.50 to $13.61. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 3 | Common | Common Stock | 2025-09-09 | M | A | 12,876 | $1.45 | 189,866 | D | — | — | |
| 4 | Common | Common Stock | 2025-09-11 | S | D | 41,121 | $13.08 | 176,990 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $12.98 to $13.17. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 5 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-09-09 | M | D | 12,876 | $0.00 | 41,121 | D | $1.45 · — to 2028-03-19 | 12,876 Common Stock | (F3) These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones. |
| 6 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-09-11 | M | D | 41,121 | $0.00 | 0 | D | $1.45 · — to 2028-03-19 | 41,121 Common Stock | (F3) These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones. |